🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 50127T109
- Market Cap
- Mid Cap
- IPO
- 11/5/2015 · $8.00/share
- Previous Symbol
- KURO (changed 11/5/2015)
Business: Kura Oncology, Inc. is a a clinical stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Kura focuses on the development of small molecule product candidates that target cell signaling pathways that are important to driving the progression of certain cancers.
Company Contact
- CEO
- Troy Wilson
- CFO
- Marc Grasso
- Headquarters
- 12730 High Bluff Drive, Suite 400, San Diego, CA 92130
- Phone
- 858-500-8800
- Investor Relations
- Robert H. Uhl, Westwicke Partners, LLC · 858-356-5932 · robert.uhl@westwicke.com